VIDEO: Why LSB Industries Could Double
Tough times for pharma stock Theravance, a boost for a mini-congolerate, and better news ahead for CIT.
Read MoreTough times for pharma stock Theravance, a boost for a mini-congolerate, and better news ahead for CIT.
Read MoreWe use cookies to improve your experience. You can choose which types of cookies to accept. Read our Privacy Policy.
Choose which cookies to enable: